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The Healthy Living Pharmacy (HLP) project, launched in England, UK in 2009 was a novel
approach of introducing public health services within community pharmacy to tackle local
health inequalities. A national roll-out followed a reported successful pilot; subsequent local
evaluations ensued.
Objectives
To summarise reported outcomes and investigate contextual factors that indicate the pres-
ence, absence and maturity of implementation determinants, thus offering useful lessons to
stakeholders in implementing future initiatives to achieve successful outcomes.
Methods
A systematic review was conducted to identify all publications reporting on the HLP project.
All HLP articles and conference abstracts were considered for inclusion and were assessed
for methodological quality. The Consolidated Framework for Implementation Research
(CFIR) was utilised to identify potential implementation determinants reported. Each article
was then analysed to identify reported economic, humanistic or clinical outcomes.
Results
The review included six peer-reviewed journal articles and 12 conference abstracts. Joanna
Briggs Institute Qualitative Assessment and Review Instrument indicated deficiencies in
methodological quality. Through adoption of the CFIR framework, the implementation deter-
minants relevant to the implementation of HLP into community pharmacy were identified. A
resonating issue emerged in that the absence of adopting an evidence-based implementa-
tion process limited the ability to capture meaningful outcome data. This resulted in a lack of
evidence to support sustainability and the failure to address many of the well cited barriers,
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e.g. lack of awareness amongst patients, public and other healthcare professionals, and
weak support for future investment in resource for training and dissemination.
Conclusions
Healthcare systems are increasingly called on to adopt evidence-based interventions that
improve quality, control costs, and maximize value, thus offering opportunity to accelerate
the implementation of clinical pharmacy services and programs aimed at improving patient
care. Interventions, such as the HLP project require focused efforts on implementation and
evaluation of those implementation efforts to produce effective and lasting changes in com-
plex health care systems.
Introduction
The 2008 White Paper: Pharmacy in England: building on strengths, delivering the future,[1]
described the role community pharmacy could play in supporting public health through
becoming healthy living centres. Recommendations were made to increase pharmacy’s contri-
bution to promoting better health, prevention and early detection of disease and managing
patients with long-term conditions. The development of the concept of the “healthy living cen-
tres” was commissioned by the Department of Health (DoH) to Portsmouth Primary Care
Trust in 2009. The project was named ‘The Healthy Living Pharmacy (HLP) project’.
The HLP model is based on a tiered framework that is designed to quality assure the deliv-
ery of specific services to meet local public health demands.[2] It consists of three levels of
advancing service provision, each level underpinned by several key principles. Firstly, the ser-
vices are tailored to local health needs with the aim of reducing health inequalities by improv-
ing health and wellbeing outcomes in their communities. Secondly, a HLP builds on existing
core pharmacy services (Essential and Advanced) with a series of Enhanced Services (Table 1).
[3]
Finally, the delivery of services is supported by three enablers: workforce development, with
the introduction of Health Living Champions (HLCs); premises fit for purpose, including a
space to facilitate private consultations within the pharmacy and a dedicated health promotion
area; and, local stakeholder engagement, including local General Practitioners (family doctors)
and members of the public.
This community pharmacy initiative attempted to address a number of recognised imple-
mentation determinants established in the related literature. The introduction of a dedicated
health promotion area and a space for private consultations, as well as stakeholder engagement
aimed to enhance poor public understanding of the role of pharmacists[4] and the professional
Table 1. NHS (Pharmaceutical Services) Regulations 2005 in England. [3].
A.Essential services and clinical governance: Essential services are provided by all pharmacy contractors and are
commissioned by NHS England. Examples include dispensing, disposal of unwanted medicines and public health.
Clinical governance includes patient safety incident reporting, an information governance program, patient and
public involvement in service delivery and premises requirements.
B. Advanced services: These are provided by all contractors once accreditation requirements have been met and are
commissioned by NHS England. Examples include Medicines Use Reviews and the New Medicine Service.
C. Locally commissioned enhanced services: These are commissioned by Local Authorities, Clinical
Commissioning Groups and NHS England in response to the needs of the local population.
https://doi.org/10.1371/journal.pone.0213607.t001
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isolation of community pharmacists,[5] and address the lack of a space for private consulta-
tions.[4] These factors have been cited as barriers to the successful implementation and
embedding of community pharmacy initiatives in the UK[6, 7] and in the US, among other
countries, for example in introducing pharmaceutical care in community pharmacy.[8] A
recent independent review commissioned by the National Health Service (NHS) in England
also lists these factors, amongst others, that are recognised as barriers to community pharmacy
providing clinical services.[9] The involvement and training of non-pharmacist team members
attempted to facilitate the effective delegation of responsibilities to pharmacy support staff and
enhance the skill-mix as advocated in previous studies.[10, 11] Prior to this, commissioners
had continued to focus on remuneration as the single most important factor in introducing
innovative services into community pharmacy with little consideration to other factors.[12]
This frequently resulted in poor uptake of the service and consequent discontinuation of
commissioning.[13–16]
A model for HLP was launched in December 2009 through publication of a local HLP pro-
spectus. This was informed by a systematic review of the evidence for the role of community
pharmacy in a range of services to support their inclusion in the HLP initiative.[2] Community
pharmacies were invited to apply to be Level 1 HLPs, which required participation in the fol-
lowing services: wellbeing and self-care, including active health promotion campaigns, opti-
mising medicines including delivering targeted respiratory Medicines Usage Reviews (MURs);
accredited pharmacists undertaking structured adherence-centred reviews with patients on
multiple medicines, particularly those receiving medicines for long-term conditions) and pro-
viding two enhanced services, one of which had to include smoking cessation. The full accredi-
tation criteria are detailed in S1 Table.
To meet the ‘workforce development’ enabler requirement, at least one non-pharmacist
member of the pharmacy team was required to become a qualified HLC by achieving an
accredited qualification in understanding health improvement. This was intended to be an
individual with an interest in public health and a commitment to the HLP concept.
A local evaluation of the HLP project demonstrated an increased uptake of community
pharmacy services in Portsmouth, which informed the roll-out of a national pathfinder pro-
gramme across England[17, 18]. The HLP models in these pathfinder sites were similar to the
Portsmouth model, but with local variation in the services that were commissioned and the
support that was provided to HLPs. More recently, the National Health Service in England
introduced a Quality Payments Scheme, which provided a financial incentive for community
pharmacies to become accredited as HLPs, among other quality initiatives.[19]
As a result of the national roll-out, there is now a small but growing body of literature
reporting on the implementation and outcome data of HLP, but a review of these individual
studies to examine trends in challenges to implementation and the quantitative service data of
HLP has not yet been reported. It has been argued that in recognising these determinants,
intervention benefits can be optimised, sustainability of the intervention can be prolonged,
and dissemination of findings into other contexts can be enhanced.[20] Moreover, in review-
ing the reported outcome data, it will be possible to identify, if any, the economic, humanistic
and clinical outcomes.
The barriers and facilitators of introducing new services into community pharmacy has
been reported in the literature,[12, 21, 22] however, implementation science research adopts
the use of theoretical models allowing researchers to systematically collect, analyse and inter-
pret appropriate data in evaluating the implementation of innovation. It is advocated that this
approach within healthcare, affords recognition of contextual and processual dimensions com-
monly linked to failures of implementing innovation.[23, 24]
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This review aims to summarise the reported outcomes of individual HLP evaluations and
investigate contextual factors included in those evaluations that indicate the presence, absence
and maturity of implementation determinants.[23, 24] This will offer useful lessons to stake-
holders in the implementation of future HLP initiatives towards achieving successful
outcomes.
Methods
Data sources and search strategy
This systematic review is reported in accordance with the Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses (PRISMA) guidelines. The study selection process
(PRISMA flow diagram) is presented in Fig 1 and the completed 27-item checklist is included
in S2 Table. The five-step principle of conducting a systematic review as described by Khan
et al. was adopted, which includes defining the research question, identifying the literature,
quality assessment of the selected literature, summarising the findings and interpreting the evi-
dence.[25]
The SPICE (setting, perspective/population, intervention, comparator, evaluation) frame-
work[26] was employed by one research team member [ZN] to design the research strategy
and included a search of MeSH (medical subject headings) terms and title/abstract terms
(TIAB) [Table 2]. The full electronic search strategy used to identify studies, including all
search terms and limits for one database (MEDLINE) is included as S3 Table. Four electronic
databases (Google Scholar, Web of Science, MEDLINE and PubMed) were searched from Jan-
uary 1st 2000 to 31st March 2018. Electronic searches were supplemented with hand citation
searches and reference list review of eligible studies. In addition, conference proceedings
Fig 1. Study selection process (PRISMA flow diagram).
https://doi.org/10.1371/journal.pone.0213607.g001
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reported in the International Journal of Pharmacy Practice (IJPP), which includes two of the
most recognised international pharmacy practice conferences and are not indexed in the
major databases) and International Social Pharmacy Workshop (ISPW) were reviewed. A con-
ference abstract was only considered for inclusion for review in this study where a full paper
on that same study was not available. A review of titles, abstracts and full texts was carried out
independently by two authors [ZN & HN]. Any disagreements over included articles were dis-
cussed with a third reviewer to mitigate against potential bias.
Any quantitative or qualitative studies published in English that reported on data on the
HLP initiative were included; no date restriction was set and articles were eligible for inclusion
regardless of the year published.
Data extraction and quality assessment
Two investigators (ZN and HN) independently evaluated the full-text of the identified articles
to determine whether they met the inclusion criteria, which were that papers must directly
concern implementation of the HLP initiative or provide HLP outcome data. Any disagree-
ments over included articles were discussed and resolved through consensus between both
investigators and, where necessary, a third reviewer was consulted.
An Excel spreadsheet was created for the purposes of data extraction, which contained a
row for each included article and columns to describe the studies and classify the extracted
data related to implementation determinants and reported outcomes. After identifying the
included studies, the two researchers reviewed each of the selected studies and assessed the
methodological quality of qualitative studies using the Joanna Briggs Institute Qualitative
Assessment and Review Instrument (JBI-QARI).[27] The Instrument includes criteria such as:
the presence of congruity between the different parts of the qualitative research; adequate
representation of all participants, and assesses the consistency of the conclusion with the analy-
sis of the results. This critical appraisal tool consists of 10 questions that address the possibility
of flaws in design, conduct, or analysis. For each question a rating of ‘yes’, ‘no’, ‘unclear’, or
‘not applicable’ was allocated. The number of ‘yes’ responses for each article was totalled to
give a score out of 10. Once completed, the two researchers met with a third investigator to dis-
cuss ratings and come to agreement on discrepancies. One point was awarded for each ‘yes’
and a total score was obtained for each study. (The quality assessment is summarised in S2
Table)
Coding and synthesis of the literature
Many theories, models and frameworks have been developed to explain and support the
implementation of interventions in healthcare. Examples of some of the more commonly used
frameworks are the Consolidated Framework for Implementation Research (CFIR),[28] the
Table 2. Generalised search terms used informed by the SPICE framework. (No comparator groups were identified)[26].
Setting Perspective/Population Intervention Evaluation
Community Pharmacy Healthy living pharmacy Outcome
Primary care Community pharmacy Healthy centre Perception
Public health Feedback
Pharmaceutical care Barrier
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Active Implementation Frameworks (AIFs),[29] and the RE-AIM evaluation framework.[30]
Uniquely, the CFIR is based on a critical review of the literature on professional services pro-
vided in community pharmacies and is the most widely cited and used in the pharmacy prac-
tice literature.[31] To synthesise the implementation determinants from the literature, the
CFIR was chosen because of its ability to situate potential implementation determinants across
a range of domains.[28] The CFIR provides a framework that specifies a list of implementation
determinants within general domains, which are believed to influence implementation based
on the strength of their support in the healthcare literature. The CFIR is composed of five
major domains: i) intervention characteristics, ii) outer setting, iii) inner setting, iv) character-
istics of the individuals involved in implementation, and v) the process by which implementa-
tion is accomplished.
Two investigators (ZN and HN) read the included articles multiple times and then indepen-
dently undertook the coding through developing a list of reported implementation determi-
nants to the implementation process of HLP. The two investigators then independently
catalogued the themes that emerged according to the CFIR framework constructs. The two
investigators then met to discuss and reconcile codes, identify emergent themes, and resolve
discrepancies through consensus. It should be noted that this involved interpretation of
whether there were findings relevant to a CFIR domain, since none of the studies adopted an
implementation framework in reporting their findings. Each article was then independently
analysed by the two investigators to identify reported outcomes, which were coded into either
economic, humanistic or clinical.
Findings
The literature search resulted in twenty publications reporting on the implementation of the
HLP or providing outcome data, which were published between 2013 and 2017 (Table 3); six
peer-reviewed journal articles and fourteen conference abstracts. Studies were predominantly
qualitative, involving case studies and interviews and/or surveys of the perceived impacts, suc-
cess factors, barriers, or satisfaction among different stakeholder groups. Sixteen of these pub-
lications included reports of implementation determinants (Table 3).[17, 32–46] Four
publications,[17, 32–34] reported on both implementation determinants as well as outcomes
of HLP involvement; and two publications reported solely on various outcomes of HLP
involvement.[47, 48] Two publications reported on the content of HLC training and therefore
did not fall into the criteria since.[49, 50] Identified articles were placed in chronological order
starting from 2013 to 2017.
The studies were conducted across England, including locations in the north, south, and
central areas of England as well as the capital, London. Studies where the focus was investigat-
ing community pharmacy staff views and perceptions were not limited to an individual phar-
macy, but rather included multiple pharmacies within a geographic location. Data was
gathered from individuals representing pharmacies located in different areas of deprivation;
city centre, urban and rural pharmacies; and in different types of community pharmacies from
the single independent to the large multiples. Where reported on, authors stated that location,
area of deprivation and type of pharmacy did not reveal distinguishable trends. Similarly, there
was no mention that size of the pharmacy, in relation to prescription volume or workforce
number, correlated to contrasting findings.
All but one study included qualitative methodologies and were subjected to appraisal using
the JBI-QARI, which revealed that deficient methodological quality was present in all of the
published studies. Scores ranged from 2 to 8, with five studies receiving a score of 8 and an
overall median score of 5. This was most notably recognised through the lack of detail relating
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to the philosophical or theoretical perspective of the research; consequently, in much of the
research it was not possible to identify congruence with the methodological approach adopted.
Furthermore, since many of the studies were conducted by pharmacists, it would have been
appropriate for a statement to have been included that located the researcher culturally and
the potential influence the researcher had on the research, including the steps taken to limit
this. To evidence transferability and dependability, four studies provided rich and contextua-
lised descriptions of the research context;[17, 39, 42, 44] however the majority of the studies
did not describe the interview context, interview duration, or examples of interview questions.
Only four studies described how interview questions were developed,[17, 37, 41, 44] and only
two studies described how they were pilot tested.[41, 42]
The findings below are presented by each of their five CFIR domains (i.e. intervention char-
acteristics, outer setting, inner setting, individual characteristics, and process); within each of
these domains there are several constructs (see http://cfirguide.org/ for a description of each
construct). The X indicates where a construct within one of the five domains was implicated as
an implementation determinant and may have acted as a barrier or an enabler in reporting the
implementation of HLP.
Table 4 provides details of the constructs identified through analysis of the published litera-
ture found to be relevant to the implementation of the HLP and Table 5 presents a summary
of the reported outcomes from the HLP literature, categorised into economic, clinical or
humanistic characteristics.
Table 3. Studies reviewed, the type of study and CFIR domains represented in each.
Consolidated Framework for Implementation Research domain











Qualitative; service provider survey X X
Nazar et al.
(2013)[35]
Qualitative; pharmacy staff interviews X X X X
Brown et al.
(2014)[17]
Mixed methods; service outcome data & pharmacy
staff interviews
X X X X X
Rutter et al.
(2014)[39]
Qualitative; pharmacy staff interviews X X X
White et al.
(2014)[40]
Qualitative; pharmacy staff interviews X X X X
Donovan et al. (2014)
[41]
Qualitative; pharmacy staff interviews X X
Patel et al. (2014)[46] Qualitative: pharmacy staff interviews and surveys X X X
Shevket et al.
(2015)[43]
Qualitative; pharmacy staff interviews X X X X
Firth et al. (2015)[44] Mixed methods; service outcome data & pharmacy
staff interviews
X X X X
Donovan et al. (2015)
[42]
Mixed methods; service outcome data & pharmacy
staff interviews
X X X X
Kayyali et al. (2016)
[49]






Cooper et al. (2017)
[45]
Qualitative; pharmacy staff focus groups and
interviews
X X X X
https://doi.org/10.1371/journal.pone.0213607.t003
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Table 4. CFIR Domains: Implementation characteristics relevant to the HLP model.
Intervention characteristic
Relative advantage Staff recognised the HLP model to provide a more proactive, supportive and
effective approach to service delivery. [35, 39, 40, 42, 44]
Staff perceived an opportunity for personal betterment in HLP involvement.
[34–36, 39, 40, 45]
Evidence strength and quality Commissioners viewed HLPs as an important delivery mechanism for public
health services.[47]
Contractors and employers felt that service commissioning was not based on
local needs.[47, 49]
Commissioners raised concerns about the lack of evidence base for the services
included in the HLP model.[47]
Adaptability Staff recognised that many of the services included in the HLP model were
already delivered in the pharmacy and were integrated into existing workflow.
[35] [41]
Cost Pharmacists did report their concerns regarding the setting up and delivery
cost. [42, 44, 45]
Outer setting
External policies and incentives Problems with receiving remuneration for service provision.[35]
Lack of awareness of both clients and health care professionals locally.[34, 35,
39, 40, 42–45]
Lack of nationally agreed accreditation criteria.[35, 47]
Cosmopolitanism Difficulties in establishing new relationships with local organisations for
patient referrals and synchronised health promotion activities.[40, 42, 43, 45]
Patient needs and resources Patient access and acceptability of services delivered through the HLP project
were positive.[32–34, 42, 43] However, access for hard to reach patients was
not considered e.g. homeless and housebound patients. [45]
Inner setting
Structural characteristics An additional computer terminal wired to the internet was identified as an
enabler to support patients in signposting and providing further advice. [17]
The lack of available space led to challenges in creating suitable area for health
promotion activities.[45]
Implementation climate Relative priority and compatibility: Tension between employers and staff
around prioritising commercial aspects of community pharmacy with the HLC
role.[35, 40]
Compatibility: Pharmacists recognised the HLC role to be crucial in furthering
progress with HLP accreditation and supporting the delivery of services.[17,
41, 45]
Learning climate: Staff were motivated to undertake new learning and advance
their role to benefit patient care.[35, 36, 39, 43, 49]
Readiness for implementation Available resources: The convenience, time and cost investment of training
staff posed an obstacle to undertake the HLC course. [17, 49]
Access to knowledge and information: HLCs used their network for peer-
learning and obtaining advice and information.[36, 38].
Characteristics of individuals
Knowledge and beliefs about the
intervention
Staff felt that the HLP model provided greater job satisfaction and enhanced
their professional development and confidence.[17, 36, 39, 45]
Staff reacted positively to the HLP concept and the services included.[39, 44,
45]
Other personal attributes Staff were enthusiastic and motivated to explore opportunities to do different
activities afforded by the HLP model.[35, 39, 40, 45, 49]
Individual identification with
organisation
Staff perceived the HLP model to be a natural extension of their current roles
and believed that the model fitted the ethos of community pharmacy.[17, 39,
41, 45]
Process
Engaging Champions: HLCs supported staff with customer engagement.[17, 36, 42, 45]
External change agents: Little work by commissioners to raise local awareness
and encourage involvement of local health and social service.[40, 45]
External change agents: Commissioners demonstrated a poor understanding of
the HLP framework. [42, 44]
(Continued)
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Discussion
Our appraisal of the published research has highlighted that the current body of literature has
insufficiently addressed the possibility of bias in its design, conduct and analysis. Furthermore,
a key review article which contributed to the evidence base for the national role-out of HLP
contained a lack of both theoretical underpinnings and analysis transparency.[51] It has been
advocated that a formative, theory-based approach be taken in conducting evaluations of ini-
tiatives in pharmacy practice.[52, 53] This includes recommendations that evaluations account
for the iterative nature of health care improvement work and are undertaken prospectively,
generating learning applicable to ongoing improvement efforts and enabling midcourse
adjustment to the initiative. Moreover, it has been recommended that such initiatives are
resourced to include a trained programme evaluation researcher to conduct this work.[54, 55]
The findings relating to the implementation determinants are discussed with reference to the
relevant constructs within each domain.
Intervention characteristics of the CFIR
Relative advantage, evidence strength and quality, cost and design quality and packaging were
found to be relevant implementation determinants for the HLP model in community phar-
macy (Table 4).The community pharmacy stakeholders interviewed in the reported studies
perceived that HLP involvement would offer benefits to the public as well as providing oppor-
tunities for professional development. It is important to note, however, that the majority of the
reported studies were conducted with pharmacy staff employed in pharmacies working
towards or which had achieved HLP accreditation; very few reports included the perceptions
of staff employed in pharmacies that were not working towards HLP accreditation. It can
therefore be argued that the sample populations included in the studies may have been biased
and the relative advantage, which referred to pharmacy staff perceiving advantages of imple-
menting the HLP model, may not be perceptions held by the wider pharmacy staff population.
This observation has been recorded in related literature which recognises the concept of ‘Lead-
ing Edge Practitioners’ (LEPs).[56] LEPs have been identified as enablers of successfully imple-
menting innovation, through adopting a proactive approach to integrating new methods of
working, focussing on staff development, networking with peers and establishing channels to
enhance their influence. LEPs have also been recognised as individuals who are more likely to
Table 4. (Continued)
Planning The absence of a facility for disseminating and sharing HLP information was
recognised as a barrier.[36, 42, 45]
Reflecting and evaluating The lack of communication regarding local and national progress with HLP
propagated feelings of isolation.[17, 36, 45]
https://doi.org/10.1371/journal.pone.0213607.t004
Table 5. Summary of reported HLP outcomes.
Reported outcomes
Economic Evidence that service users would have gone to their family doctors, or would have done nothing if
they had not accessed the community pharmacy service. [32, 33]
Clinical The smoking cessation programme run in HLP accredited pharmacies supported a larger number of
patients to reach a 12-week quits [17, 48].
Humanistic The public reported HLP accredited pharmacies as a new option to access health and well-being
services, which were convenient and timely. [17, 32, 34]
https://doi.org/10.1371/journal.pone.0213607.t005
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participate in evaluative research to contribute their experiences to the development of profes-
sional initiatives. It is unclear from the published studies whether these reported perceptions
stemmed from local communications of HLP developments or whether reports of HLP in the
national press had propagated these positive perceptions towards the initiative.
In many of the studies, it was found that achieving the HLP accreditation criteria had not
been perceived as unduly challenging, since a large number of community pharmacies had
already been offering the majority of the services that the HLP initiative had intended to pro-
mote. In contrast, in those pharmacies which had not previously offered these services, staff
reported their concerns of the cost of implementation as a barrier, which delayed and in some
cases deterred their involvement. Although it was not stipulated what these costs referred to,
further analysis of the various implementation resources suggested that the only visible costs
related to costs incurred by sending staff on training courses and forecasted costs of rearrang-
ing workflow in the pharmacy to manage the potential demand for services.
The few studies which focussed on the views of commissioners described their belief that
the HLP initiative could pose an important delivery mechanism for commissioning public
health services. However, they shared their scepticism over the evidence base for the services
encompassed in the initiative and discussed the need to assess the design of the initiative
according to local needs and resources.
The current data indicates that the HLP initiative provides a framework to structure and
motivate public health services in community pharmacy. However, concern has been
expressed about the evidence for the effectiveness of these services and that the extra cost may
not warrant the training and resourcing for services already provided within community phar-
macy outside the HLP model.[45, 47] Given that studies until now do not provide a great deal
of outcome data to assess the effectiveness of HLP with regards to economic, clinical and
humanistic outcomes, the expressed concerns may potentially remain unaddressed and limit
the sustainability of the HLP model.
Outer setting of the CFIR
Generally, the outer setting includes the economic, political, and social context within which
an organization resides;[28] Table 4 provides an overview of the relevant outer setting con-
structs observed in the HLP literature.
The outer setting constructs that appeared to be most relevant were ‘external policies and
incentives’, ‘cosmopolitanism’, and ‘patient needs and resources’.
The earlier studies reported community pharmacy staff frustrations with the cumbersome
process of claiming reimbursement for the delivery of HLP services.[17, 35] Subsequently, the
paper-based method that required postal submission to the commissioners at the end of each cal-
endar month was replaced with PharmOutcomes, a flexible, integrated web-based system that
facilitates recording and analysing service details and submission of data to the commissioners.
The outer setting construct that appeared to be reported most frequently was that of the
wider awareness of the HLP initiative. It was reported in the majority of studies that commu-
nity pharmacy customers, the public and local health care professionals appeared to have had
little, if any, awareness of the initiative and that this was perceived to contribute to challenges
in recruitment to HLP services and developing relationships with local organisations affiliated
to HLP initiatives. This finding is consistent with a recent Royal Pharmaceutical Society (RPS)
study, which includes poor public understanding of the role of pharmacists and community
pharmacy being professionally isolated and marginalised within the National Health System
(NHS) as barriers to implementing innovation in community pharmacy.[57] Similarly, this
finding reflects reported barriers cited in the wider related literature.[8]
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The lack of consistent accreditation criteria across different geographic commissioning
regions many well have been a factor, which deterred a large national multiple pharmacy chain
from supporting the HLP initiative.[44] It was reported that without a set of consistent accredi-
tation criteria, the level of investment could not be determined; this has since been addressed
with the embedding of the criteria in the national community pharmacy contractual frame-
work.[58]
Studies in which patient feedback was collected indicated that patients who had accessed
HLP services reported positive experiences with regards to receiving the service through com-
munity pharmacy, which is consistent with the related literature concerning patient experience
with community pharmacy services.[4] However, it was reported that although the HLP initia-
tive targeted local health inequalities, there was little attention directed towards homeless and
housebound patients who are often in the most need of additional services.
The poor public and patient awareness of the roles and capabilities of pharmacists has been
documented in a systematic review,[4] which reported that consumers may regard pharma-
cists as appropriate providers of public health services but often lacked confidence in their abil-
ity. Those consumers who had accessed such services in community pharmacy reported good
satisfaction with the experience and the review recommended that further training and oppor-
tunity should be provided to pharmacists to increase public confidence and awareness. Despite
this training and opportunity being part of the HLP model, patient perceptions broadly appear
to be similar to those captured by Eades et al.[4] This review offers some insight on this issue,
in that the time to achieve change in perception is lengthy and research may not start to cap-
ture this until there has been a sustained delivery of public health services through HLP.
Inner setting of the CFIR
Aspects of the organisational culture, structure and politics that reflects receptiveness to
change and new ways of working in the organisation are categorised as inner settings.[28]
Table 4 provides an overview of the relevant inner setting constructs observed in the HLP
literature.
Structural characteristics did not appear as prevalent implementation determinants; where
these were cited it was generally by staff employed in smaller pharmacies, where issues such as
inadequate available space to support health promotion activities were reported.
The implementation climate refers to both positive and negative implementation determi-
nants. The compatibility of the HLC role seemed to vary in the separate reports; since the role
was identified as a key enabler for HLP accreditation in a large number of pharmacies through
contributing to staff training and championing the various HLP services. In contrast, in others,
a tension developed between staff around the selection of the HLC role and further reports
indicating the HLCs were not given the time by management to perform their role. Studies
investigating an extended role of pharmacy support staff have identified a similar trend, in that
more senior staff in the pharmacy are reluctant to delegate work and pharmacists reported a
lack of confidence in the abilities of support staff.[59, 60] There was no mention in the
reported studies of how this tension was managed in an attempt to successfully integrate the
role of the HLC into the daily workflow.
Similarly, the learning climate, which refers to the motivation of staff to undertake new
learning and the supportive environment to try new methods was identified as a positive
implementation determinant. The enthusiasm of community pharmacy support staff to
undertake further training and enhance their role in delivering services concurs with the lim-
ited literature in this area.[61] Despite this willingness to undertake further training, it was fre-
quently mentioned that the inconvenience, time and cost investment for staff to undertake the
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HLC course was a barrier to achieving HLP accreditation. Although in the majority of cases,
this was funded by local commissioners, the absence of a staff member from the pharmacy
during the training period often caused an inconvenience and a cost implication to the
pharmacy.
In more recent published reports, there was mention of the development of a HLC commu-
nity of practice, which was used for peer-learning, seeking advice and obtaining information
relevant to HLP accreditation.[36–38] This was identified as an enabler for HLP implementa-
tion and a potential resource for investment to support sustainability, however, to date there
are no reports describing a wider adoption of this strategy.
Individual characteristics of the CFIR
Table 4 provides an overview of the relevant individual characteristics constructs observed in
the HLP literature.
The large majority of studies reported pharmacy staff enthusiasm and motivation to explore
the opportunities, and undertake the different activities afforded by the HLP model. In two of
the studies, it was reported that the local HLP launch event had contributed to individuals’
enthusiasm since these events were designed in such a way that supported the participation of
attendees to offer their thoughts on the design and implementation of the initiative. The litera-
ture recognises that this approach can enhance buy-in of the stakeholders involved and pro-
motes the decision to adopt an innovation.[62]
Community pharmacy staff tended to perceive that participation in the HLP initiative was a
natural progression of their existing roles and fitted with their perceived values of community
pharmacy. This observation is congruent with similar studies investigating pharmacy staff per-
ceptions of introducing new services into the pharmacy.[63] The knowledge, confidence and
skills gained by pharmacy staff completing the HLC course was frequently cited as a crucial
factor and often a driver of implementation. However, it should be noted that the majority of
studies investigating the views within community pharmacy were conducted with pharmacy
teams who had made the decision to participate in the initiative and who were motivated to
partake in the evaluative study. The views of pharmacy staff employed in pharmacies not
involved in the HLP initiative is less well reported.
Process
Table 4 provides an overview of the relevant process constructs observed in the HLP literature.
The process constructs identified in the literature were discussed with regards to their
absence and subsequent detrimental effect on the implementation process. The lack of external
change agents and poor communication to disseminate relevant HLP information was recog-
nised as a barrier to HLP implementation and propagated feelings of professional isolation.
Although the introduction of the HLC role was widely considered to be a key enabler of
HLP implementation in supporting staff training, influencing the attitudes and beliefs of their
colleagues within the pharmacy and role-modelling good practice, their influence was largely
limited to the pharmacy in which they worked. A lack of individuals who influenced or facili-
tated intervention decisions in a desirable direction, such as investing in enhancing wider pub-
lic awareness of the HLP model was noted as a barrier in furthering the HLP agenda.
The description of the HLC role in these studies resonates strongly with the similar work
describing the role of champions within community pharmacy in the implementation of new
services. Pemberton et al.[64] drew on extant research, including studies from community
pharmacy, in supporting the notion that innovation is facilitated and supported by innovation
champions. Similarly, the research concluded that in order for innovation champions to
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succeed in promoting innovations in organisations, they needed both procedural and resource
support, as well as social and cognitive support. The authors recognised that the influence of
innovation champions came through social contacts, multiplied through the communities in
which they participate, through the genuine esteem in which they are held. The authors recom-
mended that developing a community around such champions makes practical sense for orga-
nisations and will potentially initiate further innovative practices.
Moreover, it has been recorded in a review of commissioning in community pharmacy ser-
vices by the University of Manchester that the lack of an ‘external’ champion, such as a phar-
maceutical advisor within the commissioning organisation, is likely to result in the
discontinuation of a new community pharmacy service.[5]
Reported outcomes
Table 5 provides a summary of the reported HLP outcomes observed in the literature.
In the majority of studies, the reported economic outcomes were based on staff perceptions
rather than a robust cost-analysis of pre and post involvement in HLP involvement. This
included staff perceptions that pharmacy income had increased through delivering more
commissioned services in pharmacies working towards HLP accreditation.[35, 39, 46] Further
studies revealed that pharmacy customers, reported a greater awareness of community phar-
macy services, and a customer survey distributed nationally to customers who had used the
services of an accredited HLP reported that 60% customers (n = 1034) would have otherwise
visited their family doctor, which the authors argue, contributed to a potential cost saving to
the NHS.[32] To date, there are no published reports that included a cost-analysis of HLP
involvement; the commercial sensitivity of accessing service delivery and income data has
been cited as a barrier to conducting an evaluation of this type.
Humanistic outcomes revealed the public’s acceptability of accredited HLP pharmacies as a
new service provider to access health and well-being services, thereby increasing the potential
options for the public to choose from. A recent systematic review revealed that whilst the liter-
ature most commonly reported that patient and public opinions about community services are
positive, awareness of pharmacy services beyond medicines supply remains low.[65] Despite
the finding of this present study indicating the public recognising HLP accredited pharmacies
as a new option to access health services, the wider literature reports that patients still look to
their physicians as their first point of access.[65]
The only published study to report service delivery data was the Portsmouth HLP pilot
evaluation, which indicated HLP accredited pharmacies and pharmacies working towards
accreditation successfully recruited and supported a greater number of customers to health
and well-being services and medicines review services. However, other than demonstrating
an increased proportion of smoking cessation clients abstaining from smoking after
12-weeks from the quit date, no other clinical data was reported. Furthermore, the report
did not reveal whether or not these pharmacies were more active than others prior to
becoming HLPs. Similarly, an unpublished report describing higher service provision in
HLP accredited community pharmacies across one geographic location in England failed to
report a baseline and therefore such observations were vulnerable to misinterpretations.
[66]
Summary of key findings
• This systematic review offers the first review of the published studies reporting on the HLP
initiative and outcome data since its inception in 2009.
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• Through adoption of the CFIR framework, this study has identified the implementation
determinants relevant to the implementation of HLP into community pharmacy.
• A resonating issue emerged in that the absence of adopting an evidenced-based implementa-
tion process has limited the ability to capture meaningful outcome data. This has resulted in
a lack of evidence to date to support sustainability and the failure to address many of the well
cited barriers e.g. lack of awareness amongst patients, public and other healthcare profes-
sionals, weak support for future investment in resource for training and dissemination.
Study strengths
It has recently been argued in the literature that application of implementation science in phar-
macy practice is “long overdue” to promote the understanding or systematic testing of optimal
ways to support implementation and sustainability.[67] In adopting the CFIR framework to
analyse and interpret the reported implementation determinants of the HLP model, it has
been possible to provide a description of reported innovation attributes that have been impli-
cated in the implementation of HLP, namely the perceived relative advantage and adaptability
of the model. Further, this study recognises the significant role of inner and outer settings,
including the reported lack of public awareness and collaboration of local health care provid-
ers, and the organisational attributes that promoted or discouraged the implementation.
In recent times, researchers and commissioners have focussed on remuneration as the single
most important factor in introducing innovation in community pharmacy with little consider-
ation to other factors. However, it is now beginning to be acknowledged that implementation
processes that attempt to address individual factors in isolation are unlikely to be successful.
Change management research demonstrates that an understanding of social trends and forces
affecting an organisation is essential to facilitate effective change.[68] This study provides fur-
ther evidence of this phenomenon within the areas of pharmacy practice and public health.
This review also indicates how the implementation of the HLP model has failed to follow a
series of recommended steps that would facilitate assessment and monitoring of success and
sustainability. Crespo-Gonzalez et al. argues that innovative services should be well defined in
relation to the target population, context, objectives, methodology outcomes and expected
benefits. An impact assessment for key outcomes, patient and economic, via a pilot study,
would also test for feasibility and a process evaluation would determine factors impacting on
service success.[69] A recent case report of a pharmacist-led medication review service
describes an implementation-effectiveness study. This demonstrates how the processual and
contextual information and specific outcomes from the implementation procedure can be
mapped out towards better understanding and assessment of the intervention in terms of clini-
cal, humanistic and economic outcomes.[70]
Study limitations
A limitation of this review is that of the twenty publications included in this study, the majority
were conference abstracts (fourteen) which are often short reports of actual studies, presenting
information that help practitioners and researchers to decide whether to attend a presentation.
Some of the publications were written by authors of this study, which could be viewed as a lim-
itation, although the quality assessment was conducted by at least one researcher who was
independent of each publication included. Crucial study information is often missing in
abstracts and suboptimal reports can impede the determination of the quality of the study and
assessment of whether reliable conclusions can be drawn. This can often be a major obstacle to
evidence synthesis. Guidance and checklists exist that can facilitate better reporting of
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interventions to allow for better description and assessment. These should be used as a stan-
dard to progress research and evidence further.[71] Moreover, there were no examples in the
studies included where implementation literature was cited, thus findings were reported as
observations and themes derived from the data, rather than adopting a framework approach to
support interpretation. This posed a challenge for the researchers (ZN and HN) to interpret
reported findings in relation to the CFIR domains and constructs, therefore analysis of
included studies was carried out independently and any disagreements were discussed and
resolved through consensus between both investigators and a third reviewer where necessary.
Conclusion
This review has successfully collated the published literature relating to the Health Living
Pharmacy model and provides detail of its reported evidence-base. With the exception of one
study conducted by the research team in Portsmouth, the published studies do not include ser-
vice delivery data from community pharmacies, but rather focus on the self-reported impact of
introducing HLP. The majority of the literature consists of cross-sectional studies involving
small samples of community pharmacy staff conducted in specific geographical areas of
England. Recent changes to the community pharmacy contractual framework has seen the
introduction of payments for meeting a set of defined quality criteria, one of which is designed
around the HLP model. Further research is required to evaluate the impact these changes have
made to community pharmacy. Most importantly, the need for robust outcome data is signifi-
cant. Evidence for effectiveness will provide a powerful tool to bolster many of the implemen-
tation constructs, supporting future delivery and adoption of HLP.
The CFIR has demonstrated its value in describing the challenges of implementing the HLP
model in community pharmacy. The findings from this review emphasise the importance of
considering an evidence-based approach to the design and implementation of innovation
within community pharmacy in order to enhance the successful integration of the innovation
and its potential to contribute humanistic, economic and clinical outcomes.
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